| Friday, September 22, 2023 Starting time – 13:00 CEST: (Paris 13:00, Hong Kong 19:00, San Diego 04:00, New York 07:00, Buenos Aires 08:00) |
|
|---|---|
| 13:00 | Welcome Milton Leong, Hong Kong and Zeev Shoham, Israel |
| 13:00-14:00 | Session 1: Giants in Reproductive Medicine |
| 13:00-13:10 | Zev Rosenwaks, USA presented by Mark Hornstein, USA |
| 13:10-14:00 | Frederick Naftolin, USA presented by Neri Laufer, Israel |
| 13:10-14:00 | The Ovarian Renin-Angiotensin System (OVRAS) – an important but under appreciated driver of ovarian function Frederick Naftolin, USA |
| 14:00-14:40 | Session 2: Endometriosis and infertility |
| 14:00-14:40 | Should the risk of endometriosis-associated ovarian cancer modify the management of an intact endometrioma during the reproductive age? Johnny Younis, Israel |
| 14:40-15:55 | Session 3: The role of the ERA test in implantation failure |
| 14:40-15:25 | The role of the ERA test in implantation failure For: Nasser Al Asmar Piñar, Spain Against: Pei-Yang Hsu, Taiwan |
| 15:25-15:55 | What can we do to improve endometrial thickness? Ertug Kovanci, USA |
| 15:55-17:05 | Session 4: New standard of care: Effectiveness and Safety of oral treatment for luteal phase support in ART (An Abbott Pharmaceutical industrial session) |
| 15:55-17:05 | The Abbott Pharmaceutical Industrial Sessions will have simultaneous translations to the following languages: Mandarin, Portuguese, Russian, Spanish and Ukrainian
Latest data to REASSURE on efficacy and safety of LPS treatments in ART |
| 17:05-19:10 | Session 5: Let us maximize ART success |
| 17:05-17:40 | The Fischer Concept/Protocol-an effect on Embryo quality Robert Fischer, Germany |
| 17:40-18:00 | Triggering Ovulation with Progesterone: The Promise and Limitations of a Natural Trigger in Assisted Reproductive Technology (ART) Dmitri Dozortsev, USA |
| 18:00-18:30 | Maximizing IVF Success: Unleashing the potential of immaturely retrieved oocytes Ibrahim Elkhatib, UAE |
| 18:30-19:10 | Exploring the Benefits of Double Stimulation and Examining the Hype and Hope in Dual Triggering Christophe Blockeel, Belgium |
| 19:10-20:00 | Session 6: Fostering IVF Breakthroughs |
| 19:10-19:40 | Towards a non-invasive assessment of the pre-implantation human embryo Carmen Rubio, Spain |
| 19:40-20:00 | Advanced Decision Support Tool for IVF Urmila Diwekar, USA |
| 20:00-20:35 | Session 7: Let us learn something about chat GPT |
| 20:00-20:35 | Chat GPT: basic understanding and some guidelines to work with: A powerful tool to improve our education and research performances. Nitzan Barzilay, Israel |
| 20:35 | Closing remarks Milton Leong, Hong Kong and Zeev Shoham, Israel |
| Saturday, September 23, 2023 Starting time – 10:00 CEST: (Paris 10:00, Hong Kong 16:00, San Diego 01:00, New York 04:00, Buenos Aires 05:00) |
|
|---|---|
| 10:00-10:25 | Session 8: Translating theory in practice: Real-world experience from a center in Turkey (An Abbott Pharmaceutical industrial session) |
| 10:00-10:25 | The Abbott Pharmaceutical Industrial Sessions will have simultaneous translations to the following languages: Mandarin, Portuguese, Russian, Spanish and Ukrainian
Translating theory in practice: Real-world experience from a center in Turkey |
| 10:25-11:55 | Session 9: Cell and Gene Therapy |
| 10:25-11:05 | Prophesies for profit: Stem cells and regeneration Gerald Schatten, USA |
| 11:05-11:25 | The use of Stem cells in Reproductive Medicine Nayana Patel, India |
| 11:25-11:55 | Rejuvenation, and new aspect of stem cells Sonia Herraiz, Spain |
| 11:55-12:50 | Session 10: What are the new innovations in the field of Andrology |
| 11:55-12:50 | Can degeneration be prevented in ICSI? Sherman Silber, USA |
| 11:55-12:50 | Does varicocoelectomy or gonadotropin improve male factor infertility? Sherman Silber, USA |
| 12:50-14:10 | Session 11: The role of the ultrasound in monitoring treatment |
| 12:50-13:15 | Ultrasound as a supportive tool in reproductive medicine Martin Mienkina, Austria GE HealthCare |
| 13:15-13:35 | The differences between different methods of measuring follicles: Decision-making process Piotr Wygocki, Poland |
| 13:35-14:10 | Optimizing the ultrasound image, knowing how the tip of the needle looks at any rotating position makes safer and more effective the OPU Costas Panayotidis, Greece |
| 14:10-15:40 | Session 12: New aspects in genetics of reproductive medicine |
| 14:10-14:40 | A new paradigm for prenatal genetics screening and diagnosis Yuval Yaron, Israel |
| 14:40-15:15 | Unlocking fertility and ovarian function via human genomics Stasa Stankovic, UK |
| 15:15-15:40 | PreConceptional health and carrier screening Tina Buchholz, Germany |
| 15:40-16:45 | Session 13: Ovarian stimulation and Fertility preservation |
| 15:40-16:15 | Double stimulation Alberto Vaiarelli, Italy |
| 16:15-16:45 | Fertility preservation Elisa Gil Arribas, Spain |
| 16:45-17:20 | Session 14: From MedFemTech and JIVFww |
| 16:45-17:05 | Amplexd Therapeutics Alia Rahman, Canada |
| 16:05-17:20 | Age-related Changes in AMH in Women Seeking Fertility – A Hospital-based Study Across India Nihar Ranjan Bhoi, India |
| 17:20 | Closing remarks Milton Leong, Hong Kong and Zeev Shoham, Israel |
